Agar with Diploid

Product: DEPO-cap. Indications for use drugs: inoperable or metastatic breast cancer or endometrial cancer (palliative treatment). Preparations of drugs: an implant for injections in 2 months by 6.6 mg or 3 months to 9.9 mg nasal spray, dosed 150 mg / dose to 17.5 ml (35 mg) Injection bottles number 1. Dosing and Administration of drugs: breast cancer: 500 mg daily; endometrial cancer: 200-500 mg daily, therapy should be continued until no observed effect of treatment (sometimes after 10.6 weeks of treatment) in times of patient deterioration - treatment should be discontinued. Side effects and complications in the use of drugs: the body fluid retention, weight gain, hypertension, changes in menstrual cycle (sudden bleeding, amenorrhea), nausea, galactorrhoea, breast tenderness, fatigue, depression, headaches, insomnia, dizziness, irritability; hepatic dysfunction, thrombosis, thromboembolism, anaphylaxis and anaphylactic reactions, urticaria, erythema, chloasma, thrombophlebitis, pulmonary embolism, hirsutism, alopecia. for p / w input prolonged by 3.6 mg or 10.8 mg in a syringe-applicator with a protective mechanism number 1. Method of production of drugs: suspension for injection, 150 mg / ml to 3.3 ml (500 mg) in 6.7 ml (1000 mg) vial. (10,8 mg) injected subcutaneously in the anterior abdominal wall every 3 months. Indications for use drugs: cyclamen prostate cancer (palliative treatment), including (in ineffectiveness or inability orhiektomiyi / estrogen treatment), endometriosis, uterine fibroids, as well as symptomatic treatment and improvement of women in menopause who refused surgery (see the "Obstetrics and Gynecology. Dosing and Administration of drugs: adult men: one cap. Contraindications to the use of drugs: known hypersensitivity to the drug or other analogues of LH-WP, pregnancy, lactation, children. Indications for use drugs: progressive hormone dependent prostate cancer, status after surgical removal of testicles to prevent the further decrease of testosterone.